One GI®, a management service organization (MSO) specializing in gastroenterology, is pleased to introduce Christa Newton as its new Chief Executive Officer (CEO). With an impressive tenure of leading multi-specialty practice healthcare systems, Christa’s appointment reaffirms the organization’s commitment to top-tier patient care. Christa previously served One GI® as the Chief Operating Officer. As COO, Christa has become a trusted leader to our physician partners and embodies the values and culture central to our organization. Christa brings a wealth of experience in propelling organizations toward heightened performance, seamless integration, and robust revenue growth. Outlining her aspirations for One GI®, she…
Author: Abhay Panchal
The research delves into the varying sedation techniques employed during the double-balloon endoscopic retrograde cholangiopancreatography (DB-ERCP) procedure, a topic of debate among medical professionals worldwide. The core objective was to gauge the performance of propofol sedation, administered by non-anesthesiologists, using a target-controlled infusion (TCI) mechanism in DB-ERCP. Spanning from May 2017 to December 2020, this retrospective analysis encompassed 156 DB-ERCP patients. These individuals were either given diazepam or propofol via a TCI system for sedation. The main focus was on contrasting the instances of inadequate sedation between the two methods. The findings revealed a higher occurrence of insufficient sedation with…
ISA Pharmaceuticals announced that the first patient has been treated in its first-in-human phase 1 trial of its novel immunotherapeutic agent, which is intended as a “functional cure” for patients with chronic hepatitis B virus (HBV) infection. The HEP-PEP trial aims to examine the safety, tolerability, and efficacy of three escalating doses of ISA Pharmaceuticals’ synthetic long peptide immunotherapy vaccine, ISA104, in comparison to a placebo among patients with HBV. Leon Hooftman, MD, expressed his delight at this significant milestone in their mission to develop an effective treatment for chronic hepatitis B virus infection. Study investigators from Erasmus MC University…
This insightful article discusses the limitations and potential of generative artificial intelligence, particularly in the context of science and healthcare. It highlights that generative AI, like ChatGPT, can provide accurate information on non-controversial topics but may exhibit biases and errors when dealing with controversial or evolving subjects. The author emphasizes the need for a paradigm shift from reductionist science to systems science in healthcare, challenging the validity of randomized controlled trials (RCTs). They argue that the transition is essential for building a sustainable healthcare system and advocate for a human-computing symbiosis to generate intelligent solutions. Ultimately, the author calls for…
AI chatbots have the potential to provide accurate information on frequently asked questions related to cancer. However, they might not be as reliable when it comes to offering precise cancer treatment recommendations, according to recent research. The study suggests that while AI chatbots can be beneficial in some areas, there are limitations to their capabilities, especially in more complex and nuanced medical scenarios.
On September 1st, 2023, Gastro Health, a prominent medical group specializing in digestive and liver health, announced the completion of its partnership with Gastroenterology Consultants of Polk County in Davenport, Florida. This marks Gastro Health’s sixth collaboration in the Central Florida region. The Gastroenterology Consultants of Polk County will be joining with one board-certified gastroenterologist, Dr. Devendra S. Kahlon, and an advanced practice provider (APP). Dr. Kahlon and his team are known for treating a variety of gastrointestinal disorders and are committed to providing top-notch, personalized gastrointestinal care to the community. Joseph Garcia, the CEO of Gastro Health, expressed enthusiasm…
One GI, has named Christa Newton as its new CEO. The announcement was shared by Ms. Newton on LinkedIn. Prior to this role, she held the position of COO within the organization and has been a part of One GI since 2021. With over two decades of experience in multispecialty, multistate, private equity-backed practice management healthcare services, Ms. Newton brings a wealth of knowledge to her new role, as indicated on her LinkedIn profile.
People on Medicare may in 2026 see prices drop for 10 medicines, including pricey diabetes, cancer, blood clot, and arthritis treatments, if advocates for federal drug-price negotiations can implement their plans amid tough opposition. The Biden administration on Tuesday revealed the first 10 drugs selected for direct Medicare price negotiations in accordance with a process mandated by the Inflation Reduction Act of 2022. It’s unclear at this time, though, how these negotiations will play out. The US Chamber of Commerce has sided with pharmaceutical companies in bids to block direct Medicare negotiation of drug prices. Many influential Republicans in Congress…
Medicine is a profession that prides itself on a high standard of both ethical and professional behavior. Expectations for proper conduct by physicians commonly are applied not only at work but also in the community and on social media, even if some doctors chafe at the latter standard. For this report, Medscape asked US physicians how often and where they see other doctors behaving poorly, when their own conduct got out of line, and how misbehavior should be addressed.
Hospitals and health systems are increasingly collaborating with major tech companies to drive their digital transformations. Here are nine notable partnerships formed in the recent past: